Hard to Treat Diseases, Inc. (HTDS)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Jan 16, 16:00
More

Hard to Treat Diseases EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HTDS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade